Kailera Therapeutics reported second quarter 2026
Author: Michael
Function announced that it has partnered with NYU
Indian longevity company has moved from lab work
Collaboration aims to strengthen evidence-based
Immorta Bio’s latest blueprint argues longevit
Viome’s acquisition of Circulate Health pairs p
Innovent Biologics and Daiichi Sankyo have entere
Sana Biotechnology reported second quarter 2026 f
Coya Therapeutics provided second quarter 2026 fi
Neuro Force One appeared at the 2026 Texas High S